Citius Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -52 | -52 | -51 | -49 |
EBITDA | -10,581 | -10,969 | -9,340 | -10,124 |
EBIT | -10,634 | -11,021 | -9,391 | -10,174 |
Net Income | -10,573 | -8,544 | -9,231 | -9,943 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -8,367 | -7,786 | -6,135 | -6,800 |
Cash | 17,911 | 12,559 | 20,345 | 26,480 |
Basic Shares | 173,856 | 159,072 | 158,955 | 158,857 |
Annual Financials
| Values in thousands | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -194 | -179 | -164 | -152 |
EBITDA | -36,729 | -32,884 | -22,878 | -17,380 |
EBIT | -36,923 | -33,064 | -23,043 | -17,532 |
Net Income | -32,542 | -33,640 | -23,125 | -17,673 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -28,361 | 56,213 | 5,965 | |
Free Cash Flow | -29,060 | -28,361 | -64,257 | -16,932 |
Cash | 26,480 | 41,711 | 70,072 | 13,859 |
Basic Shares | 151,294 | 146,082 | 108,599 | 39,165 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.06 |
2024-03-31 | -$0.05 |
2023-12-31 | -$0.06 |
2023-09-30 | -$0.08 |
